Important Dates

  • Abstract Submissions are open!!!
  • Early Bird Registration Deadline
    December 30, 2024
  • First Call Registration Deadline
    April 30, 2025
  • Final Call Registration Deadline
    October 27, 2025

Rare Diseases 2025

Coalesce Research Group is pleased to announce the 3rd International Conference on Rare Diseases and Orphan Drugs, set to take place on October 27–28, 2025, in Singapore City, Singapore. This two-day conference is designed to serve as a global platform for experts, stakeholders, and advocates to discuss advancements, challenges, and opportunities in the rare diseases and orphan drugs sector.

The primary objective of Rare Diseases 2025 is to raise awareness, foster collaboration, and accelerate progress in addressing the complex needs of individuals affected by rare diseases. The conference will facilitate dialogue and knowledge exchange among diverse stakeholders involved in rare disease research, drug development, patient care, advocacy, and policy-making.

The conference may cover a wide range of topics related to rare diseases and orphan drugs, including but not limited to:

  • Disease epidemiology and genetics
  • Advances in diagnosis and screening
  • Therapeutic interventions and treatment approaches
  • Drug discovery and development strategies
  • Regulatory pathways and orphan drug designation
  • Patient-centered care and access to treatments
  • Health economics and reimbursement issues
  • Patient advocacy, support, and empowerment

Rare Diseases 2025 features keynote presentations, plenary sessions, panel discussions, poster presentations, workshops and networking opportunities. It may also include exhibits showcasing the latest advancements in rare disease research, diagnostics, and therapeutics.

Overall, Rare Diseases 2025 plays a crucial role in advancing research, innovation, and collaboration to improve outcomes and quality of life for individuals living with rare diseases

 Who Can Attend?

  • Medical Professionals: Doctors, Specialists, Nurses and Pharmacists
  • Researchers and Scientists
  • Pharmaceutical Industry Representatives
  • Patient Advocates and Organizations
  • Regulatory Authorities
  • Healthcare Administrators
  • Academics and Educators
  • Investors and Venture Capitalists
  • Government Representatives: Policymakers, Lawmakers and Government Officials
  • Industry Stakeholders

aboutus-image

Organizing Committee

Rare Diseases 2025

The 2nd International Conference on Rare Diseases and Orphan Drugs scheduled for November 04 – 05, 2024, at the Downtown Grand Hotel, Las Vegas, USA with the Theme: " Current Research on Rare Diseases and Orphan Drugs " and has witnessed an amalgamation of outstanding speakers who enlightened the attendees with their knowledge related to the field of Rare Diseases and Orphan Drugs

The conference hosted by Coalesce Research Group was marked with the attendance of renowned and brilliant researchers, business delegates and talented student communities representing more than 20 countries around the world.

The meeting was embarked with an opening ceremony followed by Keynote Sessions and followed by series of lectures (Oral & Posters) delivered by Honourable Guests and members of the Keynote forum. The highlights of the meeting were the eponymous lectures, delivered by:

 

  • Camaj R Pashko, William Paterson University, USA
  • Stephanie Collins, Bio launch Solutions, USA
  • Leanne Lester, University of Western Australia, Australia
  • Anasua Bhattacharya, Centers for Disease Control and Prevention/National Institute for Occupational Safety and Health, USA 
  • Jaroslav Novák, University Hospital, Plzen/Pilsen, Czech Republic
  • Ashley Magnavita, Carelon Research, USA
  • Beibei Xu, Peking University Health Science Center, China
  • James Dennison, Century Environmental Hygiene, USA
  • Martin R Evans, American Society for Microbiology, Washington DC
  • Najmah A Alsobahi, Makkah Health Cluster, Saudi Arabia
  • Fils Landry MPELLE, Marien Ngouabi University, Republic of Congo
  • Fernando Vásquez Paez, Ministry of Public Health, Dominican Republic
  • Giancarlo Colombo, Hospital Israelita Albert Einstein, Brazil
  • Ravi Vadapalli, University of Miami, USA
  • Tran Hau Khang, Hanoi Medical University, Vietnam
  • Shashi Kanth Muni, MSN Laboratories, India
  • Cecília M Antão, University of Lisbon, Portugal
  • National hospital of Dermatology and Venereology, Vietnam
  • Noor Aziah Zainal Abidin, Management and Science University, Malaysia
  • Farzana Sher Muhammad, University of Malaya, Malaysia
  • Robert M West, University of Leeds, UK
  • Gheorghe Giurgiu, Deniplant-Aide Sante Medical Center, Romania
  • Gotabhaya Ranasinghe, National Hospital of Sri Lanka, Sri Lanka
  • Elaheh Jafari, Islamic Azad University, Iran 
  • Jovan Baryamaujura, Ministry of Health, Uganda
  • Christine Fletcher, GSK, United Kingdom
  • Karim Khaled, Birmingham City University, United Kingdom
  • Aneeta Regi, Royal College of Surgeons, United Kingdom
  • Owino Samwel, Maseno University, Kenya
  • Polyne Nafula Wechuli, Kenya Medical Training College, Kenya
  • Carlos Oscar Rodríguez Leal, University of Guadalajara, Mexico

The two-day event implanted a firm relation of upcoming strategies in this field. We are thankful to all our Organizing Committee, speakers & Students for encouraging and supporting us to conduct the conference, workshops and catapulting the same to pinnacle of success.


If you have any feedback for us for future consideration or enhancements to this Conference, please provide your feedback to the Conference Manager,

Sarah Alexandra at rarediseases@crgconferences.org

We wish to see you all at our next event scheduled during October,27- 28, 2025, Singapore

To know more about our Upcoming Conferences, kindly click: https://crgconferences.com/rarediseases

Succesfull Past Conferences

Rare Diseases 2024

November 04 - 05, 2024

Rare Diseases London

March 25 - 26, 2024

Past Edition Highlights

Speakers Participated
Speakers Participated 100+

Countries Involved
Countries Involved 50+

Companies Participated
Companies Participated 15+

Collaborations
Collaborations 50+

Media Partners/Collaboration